To ease your pessimism on this one subject, it is

To ease your pessimism on this one subject, it is the fastest route to an approval and NP knows this. That reason alone is why it will remain a priority. BLA will take 6-10 months, or more, before there’s revenue. Longhauler’s is exploratory and will require a follow up trial. Nash could bring early money from partnerships, but not approval revenue for quite some time. Everything else is at least as far from maturing as Nash if not farther. Obviously there will be catalysts and positives from many of our future indications along the way. But for approval this is the low hanging fruit.